Aurinia Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Aurinia Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Aurinia Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aurinia Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $3.7M | 503k | 7.33 |
| 2024-06-30 | $2.9M | 507k | 5.71 |
| 2024-03-31 | $1.5M | 308k | 5.01 |
| 2023-12-31 | $2.0M | 219k | 8.99 |
| 2023-09-30 | $1.8M | 229k | 7.77 |
| 2023-06-30 | $3.8M | 392k | 9.68 |
| 2023-03-31 | $2.3M | 212k | 10.95 |
| 2022-12-31 | $610k | 141k | 4.33 |
| 2022-06-30 | $727k | 72k | 10.05 |
| 2022-03-31 | $96k | 7.6k | 12.58 |
| 2021-12-31 | $80k | 3.5k | 22.74 |
| 2020-12-31 | $1.0k | 60 | 16.67 |
| 2019-12-31 | $81k | 4.0k | 20.25 |